8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
Catalog No.: BK3U2E
CAS.RN：853029-57-9
Molecular Formula: C20H17BrN6O2
Molecular Weight: 453.29 g/mol
Purity: NLT 98%
Intermediates of Linagliptin
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA5L89 | Linagliptin API | 668270-12-0 |
| BK8KS1 | 8-Bromo-3-methyl-xanthine | 93703-24-3 |
| BK17D8 | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 |
| BK1B54 | 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione | 666816-98-4 |
| BK3U2E | 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | 853029-57-9 |
| BK6A1R | (R)-(+)-3-TERT-BUTOXYCARBO | 309956-78-3 |
| BK2H9Z | (R)-3-Piperidinamine dihydrochloride | 334618-23-4 |
| BK01EQ | 1-bromo-2-butyne | 3355-28-0 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
